Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022

SELL
$70.55 - $111.58 $7.19 Million - $11.4 Million
-101,850 Reduced 59.91%
68,155 $4.81 Million
Q2 2022

Aug 03, 2022

BUY
$50.24 - $80.48 $4.81 Million - $7.7 Million
95,675 Added 128.72%
170,005 $12.1 Million
Q1 2022

May 12, 2022

BUY
$57.98 - $93.5 $4.31 Million - $6.95 Million
74,330 New
74,330 $5.94 Million
Q4 2021

Feb 04, 2022

SELL
$88.02 - $127.79 $3.25 Million - $4.72 Million
-36,905 Closed
0 $0
Q3 2021

Nov 03, 2021

SELL
$122.75 - $162.68 $3.24 Million - $4.29 Million
-26,380 Reduced 41.68%
36,905 $4.74 Million
Q2 2021

Aug 16, 2021

SELL
$105.76 - $154.96 $2.15 Million - $3.15 Million
-20,350 Reduced 24.33%
63,285 $9.65 Million
Q1 2021

May 12, 2021

BUY
$78.5 - $126.48 $6.57 Million - $10.6 Million
83,635 New
83,635 $8.82 Million
Q3 2020

Nov 05, 2020

SELL
$45.65 - $61.81 $4.78 Million - $6.47 Million
-104,715 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$29.15 - $61.54 $3.05 Million - $6.44 Million
104,715 New
104,715 $6.44 Million
Q1 2020

May 11, 2020

SELL
$25.01 - $42.4 $4.47 Million - $7.58 Million
-178,785 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$24.55 - $38.13 $4.39 Million - $6.82 Million
178,785 New
178,785 $6.29 Million
Q2 2019

Aug 05, 2019

SELL
$23.08 - $37.01 $1.81 Million - $2.9 Million
-78,490 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$27.81 - $40.78 $1.14 Million - $1.67 Million
-41,010 Reduced 34.32%
78,490 $2.68 Million
Q4 2018

Feb 08, 2019

BUY
$28.91 - $50.0 $786,930 - $1.36 Million
27,220 Added 29.5%
119,500 $3.81 Million
Q3 2018

Nov 05, 2018

BUY
$30.85 - $50.65 $1.02 Million - $1.68 Million
33,185 Added 56.16%
92,280 $4.43 Million
Q2 2018

Aug 13, 2018

BUY
$13.95 - $32.65 $824,375 - $1.93 Million
59,095 New
59,095 $1.83 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.11B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Lisanti Capital Growth, LLC Portfolio

Follow Lisanti Capital Growth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.